Page 95 - GPD-4-1
P. 95

Gene & Protein in Disease                                        Oral-ERT in PD knockout mice with tobrhGAA



























            Figure 4. Long-term treatment and vertical hang-time measurements. We treated two groups of GAA KO mice (exon 6 ) (n = 3) 3 times a week with
                                                                                         neo
            either a 1× or 3× dose (25 or 75 μg of tobrhGAA, respectively) orally and measured the vertical hang-time over 203 days (mean ± standard deviation)
            Abbreviations: GAA: Acid a-glucosidase; KO: Knockout; sec.: Seconds; WT: Wild-type.
            Table 3. GAA/NAG (mean±standard deviation) assay of mouse tissues after administration of tobrhGAA through oral gavage
            (oral‑enzyme replacement therapy) at day 203
                                       Hindlimb tibialis anterior Skeletal Muscle  Heart  Diaphragm  Liver  Kidney
            Treated GAA KO –1×Oral tobrhGAA       0.11±0.04            0.14±0.02   0.24±0.01  0.17±0.03  0.24±0.04
            (P versus mock)                       P≤0.05               P≤0.05      P≤0.027  P≤0.06    P≤0.037
            % of WT                               14                   18          37       13        22
            Treated GAA KO –3×Oral tobrhGAA       0.13±0.01            0.13±0.01   0.25±0.01  0.21±0.05  0.23±0.01
            (P versus mock)                       P≤0.007              P≤0.08      P≤0.06   P≤0.09    P≤0.01
            % of WT                               16                   17          38       16        20
            Mock GAA KO‑ PBS                      0.07±0.044           0.065±0.044  0.08±0.14  0.05±0.009  1.35±0.02
            Wild‑type                             0.8±0.11             0.76±0.23   0.65±0.38  1.33±0.36  1.12±0.08
            Notes: bold values indicate the P value versus the mock treated. Abbreviations: GAA: Acid a-glucosidase; PBS: Phosphate buffered saline; KO:
            Knockout; tobrhGAA: Tobacco seeds expressing human acid a-glucosidase; WT: Wild-type.

            Table 4. Percentage of glycogen reduction (mean±standard deviation) in mouse tissues after administration of tobrhGAA at day
            203 (oral‑enzyme replacement therapy)
                                        Hindlimb tibialis anterior skeletal muscle  Heart  Diaphragm  Liver  Kidney
            Treated GAA KO–1×Oral tobrhGAA          659±36               616±9     429±62     840±26    680±26
            % reduction from mock                   39                   32        48         18        28
            (P versus mock)                         P≤0.05               P≤0.001   P≤0.012    P≤0.014   P≤0.18
            Treated GAA KO–3×Oral tobrhGAA          615±77               740±38    627±140    762±14    672±37
            % reduction from mock                   43                   18        24         25        29
            (P versus mock)                         P≤0.05               P≤0.03    P≤0.15     P≤0.003   P≤0.02
            Mock GAA KO                             1067±201             898±18    825±2      1016±23   939±64
            Abbreviations: GAA: Acid a-glucosidase; KO: Knockout; tobrhGAA: Tobacco seeds expressing human acid a-glucosidase.

            3.11. Assessment of spontaneous alternation in     side preference and score below 50%. Controls generally
            wild-type and GAA KO mice                          achieve a 60% – 80% correct alternation. We assessed the
            Spontaneous alternation is used to assess the cognitive   spontaneous alternative learning for cognitive ability in
            ability of rodents to choose one of the two goal arms of   the T-maze in both male and female GAA KO mice and
            the T-maze. The advantage of a free-choice procedure   wild-type-129/C57 mice from 2 to 9 months of age. We
            is that hippocampal or lesioned animals often develop a   found that a deficiency in spontaneous learning appeared


            Volume 4 Issue 1 (2025)                         9                               doi: 10.36922/gpd.1760
   90   91   92   93   94   95   96   97   98   99   100